The critical role of the colony-stimulating factor-1 receptor in the differentiation of myeloblastic leukemia cells

Molecular Cancer Research

Volumn 6, Issue 3, 2008, Pages 458-467

  Hamilton, John A ^a   Whitty, Genevieve ^a   Masendycz, Paul ^a   Wilson, Nicholas J ^a   Jackson, Jacob ^a   De Nardo, Dominic ^a   Scholz, Glen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ENZYME ACTIVITY; LEUKEMIA CELL; MACROPHAGE; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA, MYELOID, ACUTE; MACROPHAGES; MICE; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, OSM-LIF;

EID: 40949088060     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0361     Document Type: Article

References (45)

1. Metcalf D, Nicola NA. The hemopoietic colony-stimulating factors: from biology to clinical applications. Cambridge: University Press; 1995.
2. Metcalf D. Stem cells, pre-progenitor cells and lineage-committed cells: are our dogmas correct? Ann N Y Acad Sci 1999;872:289-303; discussion 303-4.
3. Kondo M, Scherer DC, Miyamoto T, et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 2000;407:383-6.
4. Janowska-Wieczorek A, Majka M, Ratajczak J, Ratajczak MZ. Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 2001;19:99-107.
5. Walker F, Nicola NA, Metcalf D, Burgess AW. Hierarchical down-modulation of hemopoietic growth factor receptors. Cell 1985;43:269-76.
6. Stanley ER, Berg KL, Einstein DB, et al. Biology and action of colony-stimulating factor-1. Mol Reprod Dev 1997;46:4-10.
7. Fontana L, Pelosi E, Greco P, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007;9:775-87.
8. Metcalf D, Hilton DJ, Nicola NA. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells. Leukemia 1988;2:216-21.
9. Shabo Y, Lotem J, Rubinstein M, et al. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood 1988;72:2070-3.
10. Tanigawa T, Nicola N, McArthur GA, Strasser A, Begley CG. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor. Blood 1995;85:379-90.
11. Aperlo C, Sevilla L, Guerin S, Pognonec P, Boulukos KE. Synergistic effects of colony-stimulating factor 1 and leukemia inhibitory factor in inducing early myeloid cell differentiation. Cell Growth Differ 1998;9:929-37.
12. Lotem J, Shabo Y, Sachs L. The network of hemopoietic regulatory proteins in myeloid cell differentiation. Cell Growth Differ 1991;2:421-7.
13. Miyauchi J, Wang C, Kelleher CA, et al. The effects of recombinant CSF-1 on the blast cells of acute myeloblastic leukemia in suspension culture. J Cell Physiol 1988;135:55-62.
14. Marks DC, Csar XF, Wilson NJ, et al. Expression of a Y559F mutant CSF-1 receptor in M1 myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation. Mol Cell Biol Res Commun 1999;1:144-52.
15. + myeloblast leukemic cells induces their differentiation to macrophages. Mol Cell Biol 1996;16:6851-8.
16. Smith SI, Weil D, Johnson GR, Boyd AW, Li CL. Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells. Blood 1998;91:764-73.
17. Metcalf D. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia 1989;3:349-55.
18. Alexander WS, Maurer AB, Novak U, Harrison-Smith M. Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. EMBO J 1996;15:6531-40.
19. Smith A, Metcalf D, Nicola NA. Cytoplasmic domains of the common β-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines. EMBO J 1997;16:451-64.
20. Begley CG. The SCL transcription factor and differential regulation of macrophage differentiation by LIF, OSM and IL-6. Stem Cells 1994;12:143-9; discussion 149-51.
21. Csar XF, Wilson NJ, McMahon KA, et al. Proteomic analysis of macrophage differentiation. p46/52(Shc) tyrosine phosphorylation is required for CSF-1-mediated macrophage differentiation. J Biol Chem 2001;276:26211-7.
22. Wilson NJ, Cross M, Nguyen T, Hamilton JA. cAMP inhibits CSF-1-stimulated tyrosine phosphorylation but augments CSF-1R-mediated macrophage differentiation and ERK activation. FEBS J 2005;272:4141-52.
23. Lotem J, Sachs L. Induction of dependence on hematopoietic proteins for viability and receptor upregulation in differentiating myeloid leukemic cells. Blood 1989;74:579-85.
24. Conway JG, McDonald B, Parham J, et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci U S A 2005;102:16078-83.
25. McLemore ML, Grewal S, Liu F, et al. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 2001;14:193-204.
26. Minami M, Inoue M, Wei S, et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A 1996;93:3963-6.
27. Nakajima K, Yamanaka Y, Nakae K, et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 1996;15:3651-8.
28. Novak U, Marks D, Nicholson SE, Hilton D, Paradiso L. Differential ability of SOCS proteins to regulate IL-6 and CSF-1 induced macrophage differentiation. Growth Factors 1999;16:305-14.
29. Zhang J, Shen B, Li Y, Sun Y. STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells. Leuk Res 2001;25:463-72.
30. Miranda MB, Xu H, Torchia JA, Johnson DE. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway. Leuk Res 2005;29:1293-306.
31. Mochida-Nishimura K, Akagawa KS, Rich EA. Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor. Cell Immunol 2001;214:81-8.
32. Hall JP, Davis RJ. Inhibition of the p38 pathway upregulates macrophage JNK and ERK activities, and the ERK, JNK, p38 MAP kinase pathways are reprogrammed during differentiation of the murine myeloid M1 cell line. J Cell Biochem 2002;86:1-11.
33. Hashimoto S, Yamada M, Motoyoshi K, Akagawa KS. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 1997;89:315-21.
34. McArthur GA, Metcalf D, Rakar S, Johnson GR. Overexpression of C-FMS in the myeloid cell line FDC-P1 induces transformation that dissociates M-CSF-induced proliferation and differentiation. Leukemia 1995;9:68-76.
35. Akagawa KS. Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Int J Hematol 2002;76:27-34.
36. Lari R, Fleetwood AJ, Kitchener PD, et al. Macrophage lineage phenotypes and osteoclastogenesis - complexity in the control by GM-CSF and TGF-β. Bone 2007;40:323-36.
37. De AK, Laudanski K, Miller-Graziano CL. Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage-colony-stimulating factor-driven macrophage differentiation. J Immunol 2003;170:6355-62.
38. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002;99:111-20.
39. Menetrier-Caux C, Montmain G, Dieu MC, et al. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998;92:4778-91.
40. Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 2000;1:510-4.
41. Keller JR, Gooya JM, Ruscetti FW. Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit. Blood 1996;88:863-9.
42. Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 1990;18:5322.
43. Cross M, Csar XF, Wilson NJ, et al. A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling. Biochem J 2004;380:243-53.
44. Cross M, Nguyen T, Bogdanoska V, Reynolds E, Hamilton JA. A proteomics strategy for the enrichment of receptor-associated complexes. Proteomics 2005;5:4754-63.
45. Sudo T, Nishikawa S, Ogawa M, et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995;11:2469-76.